About the journal
Breast Cancer: Targets and Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 4,320 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1179-1314
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,320 USD
- Articles in DOAJ
- 693
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2010-12-21
- PUBMED · 2009-08-31
- Indexing
- DOAJ · PUBMED
- APC
- 4,320 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
693
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
733
Last recorded publication year
2026
h-index
53
i10-index
301
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2010-12-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 72%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Breast cancer, targets and therapy
- Source type
- journal
- NLM unique ID (PubMed)
- 101591856
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Breast Lesions and Carcinomas
- Breast Lesions and Carcinomas
Show all subjects (50)
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Risks and Factors
- Cancer Risks and Factors
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- BRCA gene mutations in cancer
- Breast Implant and Reconstruction
- BRCA gene mutations in cancer
- Breast Implant and Reconstruction
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Cancer survivorship and care
- Radiomics and Machine Learning in Medical Imaging
- Cancer-related Molecular Pathways
- Radiomics and Machine Learning in Medical Imaging
- Cancer-related Molecular Pathways
- Male Breast Health Studies
- Immunotherapy and Immune Responses
- MRI in cancer diagnosis
- MRI in cancer diagnosis
- Immunotherapy and Immune Responses
- Male Breast Health Studies
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Cancer Genomics and Diagnostics
- Circular RNAs in diseases
- Inflammatory Biomarkers in Disease Prognosis
Keywords (DOAJ)
- breast cancer
- anticancer agents
- palliative care
- cancer screening
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ